Allgens Capital Expenditures from 2010 to 2024

688613 Stock   17.48  0.05  0.29%   
Allgens Medical's Capital Expenditures is increasing over the years with stable fluctuation. Capital Expenditures is expected to dwindle to about 20.8 M. From 2010 to 2024 Allgens Medical Capital Expenditures quarterly data regression line had arithmetic mean of  41,840,631 and r-squared of  0.05. View All Fundamentals
 
Capital Expenditures  
First Reported
2010-12-31
Previous Quarter
21.9 M
Current Value
20.8 M
Quarterly Volatility
22.4 M
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check Allgens Medical financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Allgens Medical's main balance sheet or income statement drivers, such as Depreciation And Amortization of 12.6 M, Interest Expense of 1.7 M or Selling General Administrative of 92.6 M, as well as many indicators such as . Allgens financial statements analysis is a perfect complement when working with Allgens Medical Valuation or Volatility modules.
  
This module can also supplement various Allgens Medical Technical models . Check out the analysis of Allgens Medical Correlation against competitors.

Currently Active Assets on Macroaxis

Other Information on Investing in Allgens Stock

Allgens Medical financial ratios help investors to determine whether Allgens Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Allgens with respect to the benefits of owning Allgens Medical security.